Folgen
Laureano de la Vega
Laureano de la Vega
Bestätigte E-Mail-Adresse bei dundee.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response
MA Calzado, L De La Vega, A Möller, DDL Bowtell, ML Schmitz
Nature cell biology 11 (1), 85-91, 2009
1872009
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
L Casares, V García, M Garrido-Rodríguez, E Millán, JA Collado, ...
Redox Biology 28, 101321, 2020
1412020
A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress
L de la Vega, I Grishina, R Moreno, M Krüger, T Braun, ML Schmitz
Molecular cell 46 (4), 472-483, 2012
1152012
The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway
L de la Vega, E Muñoz, MA Calzado, K Lieb, E Candelario-Jalil, ...
Biochemical pharmacology 70 (3), 369-380, 2005
962005
Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses
L Torrente, C Sanchez, R Moreno, S Chowdhry, P Cabello, K Isono, ...
Oncogene 36 (44), 6204-6212, 2017
872017
Heat shock factor 1 is a substrate for p38 mitogen-activated protein kinases
S Dayalan Naidu, C Sutherland, Y Zhang, A Risco, L de la Vega, ...
Molecular and cellular biology 36 (18), 2403-2417, 2016
812016
Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-κB, NFAT, and activator protein 1 signaling pathways
R Sancho, A Macho, L de La Vega, MA Calzado, BL Fiebich, ...
The Journal of Immunology 172 (4), 2341-2351, 2004
812004
HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop
VV Saul, L de la Vega, M Milanovic, M Krüger, T Braun, K Fritz-Wolf, ...
Journal of molecular cell biology 5 (1), 27-38, 2013
702013
Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism
F Chen, WAM Elgaher, M Winterhoff, K Büssow, FH Waqas, E Graner, ...
Nature Metabolism 4 (5), 534-546, 2022
562022
Control of nuclear HIPK2 localization and function by a SUMO interaction motif
L de la Vega, K Fröbius, R Moreno, MA Calzado, H Geng, ML Schmitz
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (2), 283-297, 2011
502011
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
S Banerjee, T Wei, J Wang, JJ Lee, HL Gutierrez, O Chapman, SE Wiley, ...
Proceedings of the National Academy of Sciences 116 (49), 24881-24891, 2019
462019
Emerging roles of DYRK2 in cancer
V Tandon, L de la Vega, S Banerjee
Journal of Biological Chemistry 296, 2021
442021
Transcription factors NRF2 and HSF1 have opposing functions in autophagy
S Dayalan Naidu, D Dikovskaya, E Gaurilcikaite, EV Knatko, ZR Healy, ...
Scientific reports 7 (1), 11023, 2017
362017
Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine
R Sancho, L De La Vega, A Macho, G Appendino, V Di Marzo, E Muñoz
The Journal of Immunology 175 (6), 3990-3999, 2005
352005
Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage
L De La Vega, J Hornung, E Kremmer, M Milanovic, ML Schmitz
Nucleic acids research 41 (11), 5731-5745, 2013
302013
The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase‐8‐dependent pathway
R Sancho, L De La Vega, G Appendino, V Di Marzo, A Macho, E Muñoz
British journal of pharmacology 140 (6), 1035-1044, 2003
302003
High NRF2 levels correlate with poor prognosis in colorectal cancer patients and with sensitivity to the kinase inhibitor AT9283 in vitro
L Torrente, G Maan, A Oumkaltoum Rezig, J Quinn, A Jackson, A Grilli, ...
Biomolecules 10 (10), 1365, 2020
282020
The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner
Y Zhang, A Gilmour, YH Ahn, L de la Vega, AT Dinkova-Kostova
Phytomedicine 86, 153062, 2021
272021
From top to bottom: the two faces of HIPK2 for regulation of the hypoxic response
MA Calzado, L De La Vega, E Munoz, ML Schmitz
Cell Cycle 8 (11), 1659-1664, 2009
262009
Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity
L Casares, JD Unciti-Broceta, ME Prados, D Caprioglio, D Mattoteia, ...
Redox Biology 37, 101689, 2020
242020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20